CENTRAL-NERVOUS-SYSTEM TOXICITY OF QUINOLONES - HUMAN AND ANIMAL FINDINGS

被引:118
作者
CHRIST, W
机构
[1] Institut für Arzneimittel des Bundesgesundheitsamles, Berlin, D-1000
关键词
D O I
10.1093/jac/26.suppl_B.219
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Quinolones have been reported to induce CNS reactions in 0.9–2.1% of cases, but severe reactions occur in less than 0.5%. Flumequine and fleroxacin, but not other quinolones, have produced convulsions in animals after systemic administration; by interventricular injection convulsions could be produced by some quinolones, but by pefloxacin only when a dose of 400 μg was reached. A possible mechanism for CNS excitation may be the displacement of GABA from receptors. Quinolones may interact with other drugs—theophylline, caffeine, non-steroidal anti-inflammatory drugs in producing CNS effects. © 1990 The British Society for Antimicrobial Chemotherapy.
引用
收藏
页码:219 / 225
页数:7
相关论文
共 30 条
  • [1] STRUCTURE-EPILEPTOGENICITY RELATIONSHIP OF QUINOLONES WITH SPECIAL REFERENCE TO THEIR INTERACTION WITH GAMMA-AMINOBUTYRIC ACID RECEPTOR-SITES
    AKAHANE, K
    SEKIGUCHI, M
    UNE, T
    OSADA, Y
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (10) : 1704 - 1708
  • [2] NORFLOXACIN AND SEIZURES
    ANASTASIO, GD
    MENSCER, D
    LITTLE, JM
    [J]. ANNALS OF INTERNAL MEDICINE, 1988, 109 (02) : 169 - 170
  • [3] ENOXACIN - A POTENT INHIBITOR OF THEOPHYLLINE METABOLISM
    BECKMANN, J
    ELSASSER, W
    GUNDERTREMY, U
    HERTRAMPF, R
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 33 (03) : 227 - 230
  • [4] CHRIST W, 1988, NS ARCH PHARM S, V337
  • [5] NORFLOXACIN - REVIEW OF SAFETY STUDIES
    CORRADO, ML
    STRUBLE, WE
    PETER, C
    HOAGLAND, V
    SABBAJ, J
    [J]. AMERICAN JOURNAL OF MEDICINE, 1987, 82 (6B) : 22 - 26
  • [6] Esch B, 1989, Verh Dtsch Ges Inn Med, V95, P717
  • [7] PEFLOXACIN - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE
    GONZALEZ, JP
    HENWOOD, JM
    [J]. DRUGS, 1989, 37 (05) : 628 - 668
  • [8] INHIBITION OF THEOPHYLLINE CLEARANCE BY COADMINISTERED OFLOXACIN WITHOUT ALTERATION OF THEOPHYLLINE EFFECTS
    GREGOIRE, SL
    GRASELA, TH
    FREER, JP
    TACK, KJ
    SCHENTAG, JJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (03) : 375 - 378
  • [9] GRUENE S, 1988, NS ARCH PHARM S, V338
  • [10] EVALUATION OF THE EFFECT OF NORFLOXACIN ON THE PHARMACOKINETICS OF THEOPHYLLINE
    HO, G
    TIERNEY, MG
    DALES, RE
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 44 (01) : 35 - 38